Co-Diagnostics Announces Updated Third Quarter 2026 Earnings Release Date and Webcast

The Quick Take
SALT LAKE CITY, Nov. 5, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it will release its third quarter 2026...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Local
FOX NEWS MEDIA'S MULTIPLATFORM COVERAGE OF 2026 MIDTERM ELECTIONS DOMINATES CABLE NEWS DELIVERING NEARLY 4.7 MILLION VIEWERS
'FOX News Democracy 26' Tops CBS News, CNN, MS NOW in Primetime, with 'Evening News' Delivering Lowest Rated Midterm Coverage of the 21st Century FOX News…
Business
Pangaea earnings beat by $0.22, revenue topped estimates
Business
Analysis-Japanese savers have rediscovered interest rates and banks are feeling it
Business
